Company / Total Assets
Ventyx Biosciences, Inc. Total Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$276.6M
FY2024
5-year range
$245.0K / $371.4M
FY2020-FY2024
Trend
-0.4%
vs FY2023
Sector context
#180 of 215
Health Care
What the data says
Ventyx Biosciences, Inc.'s total assets of $277M is lower than 84% of companies in the Health Care sector (FY2024). Declined from $371M to $277M over the past 2 years.
Based on SEC 10-K filings.
$277M in FY2024 with a 3-year CAGR of -1.7%.
Declined from $371M to $277M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 215This company $276.6M Sector average $7.5B
▼
-96.3% below sector average
Key checks
Key Insights
- 3-year CAGR of -1.7%, indicating a declining trend.
- In FY2024, total assets decreased 0.4% year-over-year.
- Ranks #180 out of 215 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $276.6M | -0.4% |
| FY2023 | $277.7M | -25.2% |
| FY2022 | $371.4M | +27.4% |
| FY2021 | $291.5M | +118872.2% |
| FY2020 | $245.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026